Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies.
Zeng W, Han C, Mohammed S, Li S, Song Y, Sun F, Du Y.
RSC Med Chem · review-article; review; journal article · DOI 10.1039/d3md00677h PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för frovatriptan. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
9 träffarSubstrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2.
Gebauer L, Jensen O, Brockmöller J, Dücker C.
J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.2c01075Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation.
Jensen O, Brockmöller J, Dücker C.
J Med Chem · journal article · DOI 10.1021/acs.jmedchem.0c02047DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.
Drug Discov Today · review; journal article · DOI 10.1016/j.drudis.2016.02.015Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.
PLoS Comput Biol · research support, u.s. gov't, p.h.s.; research-article; journal article · DOI 10.1371/journal.pcbi.1002310Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD.
J Med Chem · journal article · DOI 10.1021/jm901371vPhysicochemical determinants of human renal clearance.
Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A.
J Med Chem · journal article · DOI 10.1021/jm900403jTrend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Obach RS, Lombardo F, Waters NJ.
Drug Metab Dispos · journal article · DOI 10.1124/dmd.108.020479N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.
Xu YC, Schaus JM, Walker C, Krushinski J, Adham N, Zgombick JM, Liang SX, Kohlman DT, Audia JE.
J Med Chem · journal article · DOI 10.1021/jm9805945